A detailed history of Chemistry Wealth Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Chemistry Wealth Management LLC holds 16,098 shares of PFE stock, worth $412,913. This represents 0.12% of its overall portfolio holdings.

Number of Shares
16,098
Previous 26,638 39.57%
Holding current value
$412,913
Previous $745,000 37.58%
% of portfolio
0.12%
Previous 0.2%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$27.7 - $31.39 $291,958 - $330,850
-10,540 Reduced 39.57%
16,098 $465,000
Q2 2024

Jul 12, 2024

SELL
$25.26 - $29.6 $303,195 - $355,288
-12,003 Reduced 31.06%
26,638 $745,000
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $267,780 - $307,497
10,343 Added 36.55%
38,641 $1.07 Million
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $276,246 - $358,813
-10,572 Reduced 27.2%
28,298 $814,000
Q3 2023

Oct 11, 2023

SELL
$32.09 - $37.51 $20,152 - $23,556
-628 Reduced 1.59%
38,870 $1.29 Million
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $23,839 - $27,581
660 Added 1.7%
39,498 $1.45 Million
Q1 2023

Apr 10, 2023

BUY
$39.39 - $51.28 $78 - $102
2 Added 0.01%
38,838 $1.58 Million
Q4 2022

Jan 17, 2023

BUY
$41.75 - $54.5 $41 - $54
1 Added 0.0%
38,836 $0
Q3 2022

Oct 21, 2022

SELL
$43.76 - $53.42 $40,346 - $49,253
-922 Reduced 2.32%
38,835 $1.7 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $524,439 - $621,821
11,271 Added 39.57%
39,757 $2.08 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $865,773 - $1.07 Million
-18,924 Reduced 39.92%
28,486 $1.48 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $1.96 Million - $2.9 Million
47,410 New
47,410 $2.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Chemistry Wealth Management LLC Portfolio

Follow Chemistry Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chemistry Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chemistry Wealth Management LLC with notifications on news.